In 2014, FBC Device attracted a further capital injection to fuel its growth within alignment implant development. The capital injection from the prominent Danish state fund, the Danish Growth Fund and existing investor Sunstone have empowered the company to expand its core and build substantial clinical evidence in the years to come.
In 2013, the company's first spinal fusion implant in the Statur product line received CE mark. At the same time, the company was ISO 13485 certified demonstrating its adherence to the highest quality standards. With these accomplishments, the company is now ready to be introduced on the European and Canadian markets.In early 2005, FBC Device was founded. With initial financial support in place, FBC Device was established and initial patents filed in late 2005. In December 2010, the European patent was granted and further funding raised, and in 2011 the US patent was granted.